AXM Pharma Files Form 12b-25 With the Securities and Exchange Commission
31 3월 2006 - 12:50PM
Business Wire
AXM Pharma, Inc. (AMEX: AXJ), a manufacturer of proprietary and
generic pharmaceutical and nutraceutical products for the Chinese
and other Asian markets, announced today that it has filed Form
12b-25 with the Securities and Exchange Commission granting the
Company a 15-day extension to file its Form 10-K. for the period
ended December 31, 2005. About AXM Pharma, Inc. AXM Pharma, Inc.,
through its wholly owned subsidiary, AXM Pharma Shenyang, Inc.
("AXM Shenyang"), is a manufacturer of proprietary and generic
pharmaceutical products, which include injectables, capsules,
tablets, liquids and medicated skin products for export and
domestic Chinese sales. AXM Shenyang is located in the City of
Shenyang, in the Province of Liaoning, China. AXM Shenyang has an
operating history of approximately 10 years. For additional
information on AXM Pharma Inc., please visit
http://www.axmpharma.com.
Axm (AMEX:AXJ)
과거 데이터 주식 차트
부터 5월(5) 2024 으로 6월(6) 2024
Axm (AMEX:AXJ)
과거 데이터 주식 차트
부터 6월(6) 2023 으로 6월(6) 2024
Axm Pharma (아메리카 증권거래소)의 실시간 뉴스: 최근 기사 0
More AXM Pharma, Inc. News Articles